eMedicine Specialties > Ophthalmology > Orbit

Tumors, Orbital: Treatment

Author: Michael Mercandetti, MD, MBA, FACS, Consulting Staff, Department of Surgery, Doctors Hospital of Sarasota
Coauthor(s): Adam J Cohen, MD, Assistant Professor, Department of Ophthalmology, Northwestern University Feinberg School of Medicine; Consulting Staff and Partner, Myers Wyse Center for the Eye
Contributor Information and Disclosures

Updated: Feb 7, 2007

Treatment

Medical Therapy

Medical therapy is tailored to the diagnosis obtained by biopsy or excision. Certain situations do not require a biopsy or excision to initiate treatment. Conditions such as orbital cellulitis often are treated medically with various antimicrobial agents. Surgical intervention is warranted if there is no response to treatment or clinical worsening is evident on examination. Orbital inflammatory disease (pseudotumor) usually is treated medically with systemic steroids. Capillary hemangiomas also can be treated with nonsurgical modalities, such as steroid injections.

Surgical Therapy

With little wasted space and a lexicon of anatomical structures occupying the orbit, surgical intervention remains a challenge. Maximal operative exposure of the lesion with ginger and minimal manipulation of the orbital contents must be well orchestrated for successful surgical outcomes.

Many cutaneous and bony approaches to the orbit have been described. The surgical approach used is reliant upon the location and size of the tumor with the surgeon's skill and experience lending itself to the choice of surgical entry into the orbit. This discussion is not meant to be a comprehensive tome on orbital surgery but merely an overview of commonly described orbitotomies.

Positions that minimize an increase in intraorbital (venous) pressure are preferred during the surgical procedure. This can be accomplished with the reverse Trendelenburg position and hypotensive anesthesia to the degree that it can be tolerated medically. Orbitotomies often are described by their anatomical location or in relation to the anatomy they transgress. Approaches can be from the periocular skin or more remote locations elsewhere on the face and scalp. Additional approaches can emanate from the conjunctival plane. Intracranial approaches also can be used.

The location of the lesion directs the surgeon toward selecting the most appropriate type and location of the orbitotomy. Concerns over the facility of using a given approach and ultimately the postoperative cosmetic appearance are considerations that assume variably weighted significance in any given situation. Indubitably, if equivalent approaches are feasible, that which produces the more appealing cosmetic result most often is preferred.

Anterior orbitotomy most commonly is performed transcutaneously or transconjunctivally. Often, the transconjunctival approach denotes an incision in the vicinity of the inferior forniceal area of the lower lid with or without a canthotomy and/or cantholysis. However, in the broadest sense, it encompasses transcaruncular and transbulbar conjunctival approaches with or without the release of the recti muscles. An example of such an approach is the medial orbitotomy via the medial bulbar conjunctiva with release and then reattachment of the medial rectus. For medially located lesions, such as those encroaching on the nasal orbital apex, this approach is possible. The optic nerve also can be reached from this approach.

Those lesions located superiorly are delimited further by their medial to lateral and anterior to posterior localization. Most often, a supertemporal lesion is from the lacrimal gland and a lateral orbitotomy or one of its modifications is an acceptable approach. Those lesions more centrally located and those in a superonasal orientation can be approached from a Lynch-type incision.

Alternatively, a coronal dissection can be used. In more posteriorly situated superior lesions, an intracranial approach may be warranted. In certain cases, medial and lateral approaches can be combined to access this area.

Inferiorly, the orbital lesion is approachable from a transconjunctival or a transcutaneous approach. In either situation, it may be required to perform a canthotomy and cantholysis to achieve adequate exposure. If the contiguous maxillary sinus is involved a Caldwell-Luc approach also can be used.

Laterally located lesions are approached from a lateral orbitotomy, such as the Berke, Reese, Stallard, or Wright approach.

Preoperative Details

A systematic review and documentation of the patient's medical status is essential.

A thorough explanation of the procedure and the risks, benefits, and alternatives should be clearly explained and documented. The patient should be cognizant of the exact procedure and if a biopsy will be performed on the mass or if an attempt for total excision will be made. It is imperative that the patient be informed of the possibility of enucleation or exenteration if indicated.

Preoperative documentation of visual acuity, degree of ptosis, lagophthalmos, proptosis, pupillary and extraocular muscle function, and the amount of diplopia in all fields of gaze is necessary. External photos are strongly suggested for documentation and later review.

A meticulous review of imaging with a neuroradiologist, if necessary, is essential for planning the surgical approach and identifying the mass and impingement of surrounding orbital structures.

Intraoperative Details

During surgical intervention, periodic assessment of pupillary function is prudent. Assessing the pupil size prior to general anesthesia, after general anesthesia is induced, and after any periorbital injections containing epinephrine (prior to manipulating the globe) is worthwhile. Narcotics can cause pupillary constriction (miosis), and epinephrine can cause pupillary dilation (mydriasis). If not assessed before the orbital manipulation is undertaken, assessment as to the cause of a dilated pupil can be obscured when the pupil is checked during surgery.

Intraoperative manipulation of the globe must be adequate to allow for sufficient exposure of the operative site, yet manipulation must be gentle enough not to put undue pressure on the globe compromising vascular flow.

Extraocular muscle manipulation can trigger the oculocardiac reflex, with resultant bradycardia. The anesthesia staff should be aware of any extraocular muscle manipulation, so that the patient's heart rate can be assessed.

Bipolar cautery is preferred to avoid channeling of the current and injury to the optic nerve.

Postoperative Details

Postoperatively, the patient must be assessed with regard to vision, bleeding, and pain.

Visual insult could occur in the intraoperative period and must be assessed postoperatively at 15-minute intervals for the first hour following surgery and every 30 minutes in the second hour. Additionally, pupillary and extraocular muscle function should be evaluated in the postoperative period.

Hemorrhage can occur in the orbit and may be potentially blinding and must be scrutinized for.

Pain may be variable, but if nausea and vomiting occurs as a result of pain medications or surgery, treatment must be given to avoid this and decrease venous pressure. Increased venous pressure can cause orbital congestion and lead to compression of the optic nerve.

Follow-up

The patient is examined the day after surgery. Vision, extraocular motility, and pupillary function are evaluated and any dressing changes are performed. In sighted patients, the authors do not patch the eye for fear that a hemorrhage would remain unrecognized and result in increased orbital pressure, with resultant compromise of an essential intraorbital structure.

Complications

The most feared complication in orbital tumor surgery is loss of vision. This can be due to excess pressure with retraction the globe. Compression of the central retinal artery can lead to irrevocable blindness.

Hemorrhage can occur operatively and postoperatively with resultant compression of the optic nerve and occlusion of the central retinal artery. Hemorrhage also can occur from laceration of the anterior or posterior ethmoidal arteries.

Monopolar cauterization should be used sparingly in the orbit because the current can channel through the optic nerve and lead to visual loss.

Because of the close proximity to the anterior cranial fossa, inadvertent intracranial injury can result.

Direct perforation of the globe is possible, especially if adequate protection, such as a corneoscleral shield, is not used.

Diplopia or other extraocular muscle disturbances can be the result of neurologic or direct muscular injury.

Paresthesia is a potential complication if there is injury to the infraorbital, supraorbital, or supratrochlear nerves.

More on Tumors, Orbital

Overview: Tumors, Orbital
Workup: Tumors, Orbital
Treatment: Tumors, Orbital
Follow-up: Tumors, Orbital
Multimedia: Tumors, Orbital
References

References

  1. Ahn JY, Shim JY, Yang WI, Kim TS. Meningeal solitary fibrous tumor as an unusual cause of exophthalmos: case report and review of the literature. Neurosurgery. Jun 2001;48(6):1362-6. [Medline].

  2. Borden JA. Treatment of tumors involving the optic nerves and chiasm. Semin Ophthalmol. Mar 2002;17(1):22-8. [Medline].

  3. Bouvier D, Raghuveer CV. Aspiration cytology of metastatic chordoma to the orbit. Am J Ophthalmol. Feb 2001;131(2):279-80. [Medline].

  4. Cohen AJ, Mercandetti M, Weinberg DA. Cavernous hemangioma. eMedicine Journal [serial online]. August 2, 2006;Available at http://www.emedicine.com/oph/topic216.htm.

  5. Dutton JJ. Clinical and surgical orbital anatomy. Ophthalmol Clin North Am. 1996;9(4):527-39.

  6. Eagle RC. Eye Pathology: An Atlas and Basic Text. WB Saunders; 1999:247-83.

  7. Glasgow B, Goldberg R, Gordon L. Fine-needle aspiration of orbital masses. Ophthalmol Clin North Am. 1995;8:73-82.

  8. Goldberg RA, Lessner AM, Shorr N, Baylis HI. The transconjunctival approach to the orbital floor and orbital fat. A prospective study. Ophthal Plast Reconstr Surg. 1990;6(4):241-6. [Medline].

  9. Goldberg SH, Cantore WA. Tumors of the orbit. Curr Opin Ophthalmol. Oct 1997;8(5):51-6. [Medline].

  10. Henderson JW. Orbital Tumors. 2nd ed. Lippincott-Raven; 1980.

  11. Holmes S, Hutchison I. Reconstruction of the orbital floor after its removal for malignancy. Br J Oral Maxillofac Surg. Apr 2001;39(2):158-9. [Medline].

  12. Huh WW, Beverly Raney R. Orbital metastasis in patients with rhabdomyosarcoma: case series and review of the literature. J Pediatr Hematol Oncol. Oct 2006;28(10):684-7. [Medline].

  13. Kennerdell J, Ing E, Wang S. Orbital fine-aspiration aspiration biopsy. Ophthalmol Clin North Am. 1996;9:573-580.

  14. Kennerdell JS, Maroon JC, Malton ML. Surgical approaches to orbital tumors. Clin Plast Surg. Apr 1988;15(2):273-82. [Medline].

  15. Lane KA, Bilyk JR. Preliminary study of positron emission tomography in the detection and management of orbital malignancy. Ophthal Plast Reconstr Surg. Sep-Oct 2006;22(5):361-5. [Medline].

  16. Levine MR. Manual of Oculoplastic Surgery. Butterworth-Heinemann; 1996:281-291.

  17. Mercandetti M, Cohen AJ. Exophthalmos. eMedicine Journal [serial online]. February 7, 2007;Available at http://www.emedicine.com/oph/topic616.htm.

  18. Ohtsuka K, Hashimoto M, Suzuki Y. High incidence of orbital malignant lymphoma in Japanese patients. Am J Ophthalmol. Nov 2004;138(5):881-2. [Medline].

  19. Pfeffer MR, Rabin T, Tsvang L, et al. Orbital lymphoma: is it necessary to treat the entire orbit?. Int J Radiat Oncol Biol Phys. Oct 1 2004;60(2):527-30. [Medline].

  20. Rootman J, Stewart B, Goldberg RA. General indications for orbital surgery. In: Orbital Surgery: A Conceptual Approach. Lippincott-Raven; 1995:12.

  21. Shields JA. Diagnosis and Management of Orbital Tumors. WB Saunders; 1989.

  22. Shikishima K, Miyake A, Ikemoto I, Kawakami M. Metastasis to the orbit from transitional cell carcinoma of the bladder. Jpn J Ophthalmol. Sep-Oct 2006;50(5):469-73. [Medline].

  23. Tanaka A, Mihara F, Yoshiura T, et al. Differentiation of cavernous hemangioma from schwannoma of the orbit: a dynamic MRI study. AJR Am J Roentgenol. Dec 2004;183(6):1799-804. [Medline].

  24. Tenzel RR, Miller GR. Orbital blow-out fracture repair, conjunctival approach. Am J Ophthalmol. May 1971;71(5):1141-2. [Medline].

  25. Turbin RE, Pokorny K. Diagnosis and treatment of orbital optic nerve sheath meningioma. Cancer Control. Sep-Oct 2004;11(5):334-41. [Medline].

  26. Wojno TH. Surgical approaches to orbital disease. Ophthalmol Clin North Am. 1996;9(4):581-591.

  27. Yan J, Wu Z. Cavernous hemangioma of the orbit: analysis of 214 cases. Orbit. Mar 2004;23(1):33-40. [Medline].

Further Reading

Keywords

orbital tumors, orbital neoplasm, orbital mass, retrobulbar mass, orbital tumor, benign orbital tumor, malignant orbital tumor, orbit

Contributor Information and Disclosures

Author

Michael Mercandetti, MD, MBA, FACS, Consulting Staff, Department of Surgery, Doctors Hospital of Sarasota
Michael Mercandetti, MD, MBA, FACS is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Ophthalmology, American College of Surgeons, American Society for Laser Medicine and Surgery, American Society of Ophthalmic Plastic and Reconstructive Surgery, Association of Military Surgeons of the US, and Sarasota County Medical Society
Disclosure: Nothing to disclose.

Coauthor(s)

Adam J Cohen, MD, Assistant Professor, Department of Ophthalmology, Northwestern University Feinberg School of Medicine; Consulting Staff and Partner, Myers Wyse Center for the Eye
Adam J Cohen, MD is a member of the following medical societies: American Academy of Ophthalmology and American College of Surgeons
Disclosure: Nothing to disclose.

Medical Editor

Jorge G Camara, MD, Chairman, Department of Ophthalmology and Otorhinolaryngology, Director of Fellowship Training Program, St Francis Medical Center; Associate Professor, Department of Surgery, University of Hawaii School of Medicine
Jorge G Camara, MD is a member of the following medical societies: American Academy of Ophthalmology and American Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Mark T Duffy, MD, PhD, Consulting Staff, Division of Oculoplastic, Orbito-facial, Lacrimal, and Reconstructive Surgery, Green Bay Eye Clinic, BayCare Clinic
Mark T Duffy, MD, PhD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Ophthalmic Plastic and Reconstructive Surgery, Sigma Xi, and Society for Neuroscience
Disclosure: Allergan - Botox Cosmetic Consulting fee Consulting; Quest medical - lacrimal balloons Honoraria Speaking and teaching

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.